Key facts
- This page summarizes Michel Khalaf's Form 4 filing for METLIFE INC (MET).
- 9 reported transactions and 4 derivative rows are listed below.
- Accepted by SEC: 12 Nov 2026, 16:23.
Michel Khalaf - 10 Nov 2026 Form 4 Insider Report for METLIFE INC (MET)
- Reporting relationship
- President & CEO, Director
- Issuer ticker
- MET
- Reported as of
- 10 Nov 2026
- Net transaction value
- -$19,298,702
- SEC form
- 4
- Accepted by SEC
- 12 Nov 2026, 16:23:22 UTC
- Prior SEC filing
- 04 Mar 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Morgan Keehner-Jones Mayes, Attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Filing notes and source
Key filing fact
Michel Khalaf filed Form 4 for METLIFE INC (MET) on 12 Nov 2026.
Change
- Previous filing in this sequence was filed on 04 Mar 2026.
- Current net transaction value: -$19,298,702.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001535491
Primary reporting owner
Khalaf Michel
- Relationship
- President & CEO, Director
- Address
- METLIFE, INC., 200 PARK AVENUE, NEW YORK
- Signature
- /s/ Morgan Keehner-Jones Mayes, Attorney-in-fact
- Signature date
- 12 Nov 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
MET
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +28,817
- Change %
- +4.1%
- Price
- $46.85*
- Shares after
- 726,526
- Date
- 10 Nov 2026
- Ownership
- Direct
MET
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +34,608
- Change %
- +4.8%
- Price
- $45.50*
- Shares after
- 761,134
- Date
- 10 Nov 2026
- Ownership
- Direct
MET
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +90,726
- Change %
- +12%
- Price
- $44.65*
- Shares after
- 851,860
- Date
- 10 Nov 2026
- Ownership
- Direct
MET
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +94,578
- Change %
- +11%
- Price
- $47.58*
- Shares after
- 946,438
- Date
- 10 Nov 2026
- Ownership
- Direct
MET
transaction
Common Stock
Sale
- Transaction value
- -$19,298,702
- Shares
- -187,425
- Change %
- -20%
- Price
- $102.97
- Shares after
- 759,013
- Date
- 10 Nov 2026
- Ownership
- Direct
- Footnotes
- F1, F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
MET
transaction
Derivative
Employee Stock Option (Right to Buy)
Options Exercise
- Transaction value
- Shares
- -28,817
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 10 Nov 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 28,817
- Exercise price
- $46.85
- Footnotes
- F3, F4
MET
transaction
Derivative
Employee Stock Option (Right to Buy)
Options Exercise
- Transaction value
- Shares
- -34,608
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 10 Nov 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 34,608
- Exercise price
- $45.50
- Footnotes
- F5
MET
transaction
Derivative
Employee Stock Option (Right to Buy)
Options Exercise
- Transaction value
- Shares
- -90,726
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 10 Nov 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 90,726
- Exercise price
- $44.65
- Footnotes
- F6
MET
transaction
Derivative
Employee Stock Option (Right to Buy)
Options Exercise
- Transaction value
- Shares
- -94,578
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 10 Nov 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 94,578
- Exercise price
- $47.58
- Footnotes
- F7
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 7 footnotes
Footnote F1
The reporting person sold only the number of shares of MetLife, Inc.'s common stock necessary to pay the exercise price of the options exercised on November 10, 2026, and related tax obligations and fees.
Footnote F2
The price reported is the weighted average price of the aggregate number of shares sold in multiple open market transactions. The shares were sold at prices between $102.59 to $103.235, inclusive. The reporting person undertakes to provide to the staff of the SEC, MetLife, Inc., or a security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price.
Footnote F3
Includes 3,073 stock options previously added to the reporting person's award through an adjustment to maintain the intrinsic value of the stock options in light of the distribution by MetLife, Inc. to its shareholders of Brighthouse Financial, Inc. common stock. The reporting person did not receive shares of Brighthouse Financial, Inc. common stock on account of the stock options.
Footnote F4
The options became exercisable in three equal installments on February 28, 2018, 2019, and 2020.
Footnote F5
The options became exercisable in three installments on March 2, 2019, 2020 and 2021.
Footnote F6
The options became exercisable in three installments on February 26, 2020, 2021 and 2022.
Footnote F7
The options become exercisable in equal installments on each of the first three anniversaries of the grant date.